Figure 2From: Activity of crizotinib over choroidal metastases in Non-Small-Cell Lung Cancer (NSCLC)-ALK rearranged: a case report Basal CT-scan of the eyes (A) and after 45Â days on crizotinib (B), showing a reduction of the abnormal tissue in the left eye. Back to article page